MCKESSON CARDIOLOGY HEMO
Report
- Report Number
- 9616760-2014-00001
- Event Type
- Malfunction
- Date Received
- July 10, 2014
- Date of Event
- January 19, 2014
- Report Date
- January 19, 2014
- Manufacturer
- MCKESSON ISRAEL LTD.
- Product Code
- MWI
- PMA / PMN Number
- K131497
- Removal / Correction Number
- 9616760-06-25-2014-001-C
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- IS
- Reporter Occupation
- NOT APPLICABLE
Narratives
THE LABELING DEFICIENCY WAS IDENTIFIED INTERNALLY BY MCKESSON PERSONNEL DURING A LABELING REVIEW. MCKESSON CARDIOLOGY HEMO INCORPORATED THE FDA CLEARED ARGUS PB VITAL SIGNS MONITORING DEVICE ((B)(4)), MANUFACTURED BY SCHILLER (B)(4), WHICH PROVIDES PATIENT MONITORING CAPABILITIES AND ACQUIRES, ANALYZE AND DISPLAYS PATIENT VITAL SIGNS AND OTHER PERTINENT CLINICAL DATA. THE ARGUS PB DEVICE MUST UNDERGO RECOMMENDED ANNUAL MAINTENANCE TESTING TO VERIFY PROPER FUNCTIONING AND CALIBRATION. IF THE DEVICE IS NOT WITHIN CALIBRATION SPECIFICATIONS, THE MCKESSON CARDIOLOGY HEMO SYSTEM MAY NOT FUNCTION PROPERLY AND WHICH POTENTIALLY MAY AFFECT THE ACCURACY OF DISPLAYED CLINICAL PARAMETERS. ON (B)(4) 2014 MCKESSON INITIATED A CORRECTION TO THE MCKESSON CARDIOLOGY HEMO INSTRUCTIONS FOR USE OF THE AFFECTED CUSTOMERS VIA A FIELD SAFETY NOTICE (#PRU-10001) FOR CLARIFICATION AND REMINDER OF THE REQUIREMENTS, AND IF NEEDED, TO PERFORM AN ANNUAL MAINTENANCE TEST OF THE MCKESSON CARDIOLOGY HEMO. ANNUAL MAINTENANCE TESTING CAN BE PERFORMED BY EITHER A MCKESSON FIELD ENGINEER OR BY STAFF MEMBERS AT THE CLINICAL FACILITY WHO HAVE BEEN CERTIFIED BY MCKESSON. IF THE TESTING REVEALS THAT ONE OR MORE OF THE CLINICAL PARAMETERS FAIL THE MAINTENANCE TESTING, THE UNIT WILL BE REPLACED.
MCKESSON HAS IDENTIFIED THAT THE NEED FOR PERFORMING ANNUAL MAINTENANCE TESTING IS NOT REITERATED IN THE MCKESSON CARDIOLOGY HEMO INSTRUCTIONS FOR USE WITH VERSIONS 12.2 AND EARLIER, ALTHOUGH EACH UNIT HAS AN ATTACHED STICKER INDICATING THE DUE DATE OF THE NEXT MAINTENANCE TEST REQUIRED, AND AS COMMUNICATED TO THE CUSTOMERS AS PART OF THE USER ADMINISTRATOR TRAINING. TO DATE, THERE HAVE NO REPORTS OF AN ADVERSE EVENT, INJURY OR ILLNESS AS A RESULT OF THE LABELING DEFICIENCY DESCRIBED IN THIS REPORT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 404639 | MCKESSON CARDIOLOGY HEMO | MCKESSON CARDIOLOGY HEMO | MWI | MCKESSON ISRAEL LTD. | SW VER. 12.2 HF4 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |